ArticleGastroenterology2022
2021 Workshop: Neurodegenerative Diseases in the Gut-Brain Axis-Parkinson's Disease.
Open access · bronzeAbstract read
In one paragraph
Article in Gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Sigmoid volvulus, acute colonic pseudo-obstruction, and chronic megacolon in Parkinson disease.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026Article
- Enterococcus hirae QT4713-derived dopamine ameliorates intestinal inflammation and MPTP-induced Parkinson's disease in mice.NPJ Parkinson's disease · 2026Article
- Unraveling the Function of PPARα in Neurodegenerative Disorders: A Potential Pathway to Novel Therapies.Biomedicines · 2025Review
- Neurological perspectives and gastroenterological motility diseases: ten lessons from clinical practice.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025Article
- Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology.Frontiers in medicine · 2025Review
- Defecatory disorders are a common cause of chronic constipation in Parkinson disease.Neurogastroenterology and motility · 2024Article
- Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.Current gastroenterology reports · 2023Review
- Fecal microbiota transplantation improves VPA-induced ASD mice by modulating the serotonergic and glutamatergic synapse signaling pathways.Translational psychiatry · 2023Article
- Upper and Lower Gastrointestinal Symptom Association and Duration Preceding Parkinson's Disease.Gastro hep advances · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 8 institutions in 1 country.
Gary M MaweDepartment of Neurological Sciences, University of Vermont, Burlington, Vermont. Electronic address: gary.mawe@uvm.edu.
Kirsteen N BrowningDepartment of Neural and Behavioral Science, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
Fredric P ManfredssonDepartment of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona.
Michael CamilleriDepartment of Medicine, Mayo Clinic, Rochester, Minnesota.
Frank A HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Jonathan A HollanderNational Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland.
Beth-Anne SieberNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Patricia GreenwelNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Terez Shea-DonohueNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
John W WileyDepartment of Medicine, University of Michigan, Ann Arbor, Michigan.
National Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · USBarrow Neurological Institute · USMayo Clinic · USNational Institute of Neurological Disorders and Stroke · USPennsylvania State University · USUniversity of Michigan–Ann Arbor · USUniversity of Vermont · US
Funding
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5MBRAINSTEM CIRCUITS CONTROLLING GASTROINTESTINAL FUNCTIONR01DK055530 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROWNING, KIRSTEEN NAIRN · 1998 to 2020
$4.6MGut-brain axis in Parkinson's diseaseR01DK124098 · NIDDK · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI BROWNING, KIRSTEEN NAIRN, SUBRAMANIAN, THYAGARAJAN · 2020 to 2025
$2.6MGut-Brain Axis in Alzheimer's DiseaseR01DK108798 · NIDDK · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI MANFREDSSON, FREDRIC · 2017 to 2021
$2.1MAutoimmune mechanisms of gastrointestinal dysmotility in multiple sclerosisR01DK113800 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MAWE, GARY M · 2017 to 2020
$1.8MGenetic Control and Ileo-Colonic Mucosal Expression of Bile Acid-Related Mechanisms in Irritable Bowel Syndrome-DiarrheaR01DK115950 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2018 to 2021
$1.8MChronic Stress and Abdominal Pain: Novel MechanismsR01DK098205 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WILEY, JOHN W · 2013 to 2017
$1.7MPharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional DyspepsiaR01DK122280 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2019 to 2022
$1.5MChronic Stress and Visceral Pain: Role of Intestinal Barrier DysfunctionR21AT009253 · NCCIH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HONG, SHUANGSONG, WILEY, JOHN W · 2016 to 2017
$527kChronic Stress and Visceral Pain Heterogeneity: Role of Endocannabinoid & Epigenetic Regulatory PathwaysR21NS113127 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HONG, SHUANGSONG, WILEY, JOHN W · 2019 to 2020
$429kUse of tryptophan-synthesizing bacteria to enhance intestinal motilityR21AT011203 · NCCIH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LAVOIE, BRIGITTE · 2021 to 2022
$421kNCCIH NIH HHS R21 AT009253NCCIH NIH HHS R21 AT011203NIDDK NIH HHS P30 DK034933NIDDK NIH HHS R01 DK055530NIDDK NIH HHS R01 DK098205NIDDK NIH HHS R01 DK108798NIDDK NIH HHS R01 DK113800NIDDK NIH HHS R01 DK115950NIDDK NIH HHS R01 DK122280NIDDK NIH HHS R01 DK124098NINDS NIH HHS R21 NS113127
Abstract
PubMed holds no abstract for this paper.
Indexed as
Gastrointestinal MicrobiomeNeurodegenerative DiseasesParkinson DiseaseBrainBrain-Gut AxisHumans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.